RxDoctor Payments Data

James Chmiel, MD

Sleep Medicine · E. Amherst, NYNPI 1508810581

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,250 of the $29,883 with a category attached, or 77.8%. Medical Device Business Services, Inc. accounts for 70.3% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $13,885 and has fallen 98.2% since, to $248 in 2025. Among sleep medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,883in general payments, 2019–2025

Across 86 payments — averaging $347.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$21K
  • Acclarent, Inc$8K
  • Integra Lifesciences Corporation$490
  • Aerin Medical Inc.$197
  • GSK$125
  • Intersect ENT, Inc.$106
  • plus $281 from 3 others

What the payments were for

  • Consulting fees$23,25078%
  • Travel & lodging$3,54312%
  • Food & beverage$3,09010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,883 in reported general payments places this provider in the 90th percentile of 81 sleep medicine providers in New York.

See all sleep medicine providers in New York

Medicare billing

Part B allowed, 2024
$12,452
Medicare patients
59
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth27$3,766
Fluticasone Propionate75$1,149
Ipratropium Bromide25$838
Fluocinolone Acetonide Oil13$579
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid18$348
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$234
Methylprednisolone20$141
Omeprazole11$117
Doxycycline Hyclate14$97
Famotidine17$90
Prednisone18$88
Ciprofloxacin Hcl14$85
Mupirocin11$72
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$72
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$44

Paid to pharmacies, not to this prescriber.

Other sleep medicine in E. Amherst

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →